drugset / Trial / NCT00497536

Pharmacokinetics of IAsp Following CSII in Patients With T1DM

NCT00497536 ↗

Phase 4 Completed 12 enrolled University of Aarhus
RandomizedCrossoverOpen-labelTreatment

Summary

The primary objective of the study is to compare SSPIAsp during CSII giving one bolus per hour compared with multiple boluses per hour. The secondary objective is to compare SSPIAsp during continuous subcutaneous insulin infusion (CSII) versus continuous intravenous insulin infusion (CIII).

Timeline

Start
2007-07
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Aspart (IAsp) Unknown 100 iu Subcutaneous